- Home
- U vs JAZZ Comparison
U vs JAZZ Comparison
Compare U & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- JAZZ
- Stock Information
- Founded
- U 2004
- JAZZ 2003
- Country
- U United States
- JAZZ Ireland
- Employees
- U N/A
- JAZZ N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- U Technology
- JAZZ Health Care
- Exchange
- U Nasdaq
- JAZZ Nasdaq
- Market Cap
- U 7.8B
- JAZZ 6.5B
- IPO Year
- U 2020
- JAZZ 2007
- Fundamental
- Price
- U $22.46
- JAZZ $125.10
- Analyst Decision
- U Hold
- JAZZ Buy
- Analyst Count
- U 16
- JAZZ 14
- Target Price
- U $24.10
- JAZZ $173.93
- AVG Volume (30 Days)
- U 11.7M
- JAZZ 686.5K
- Earning Date
- U 11-07-2024
- JAZZ 11-06-2024
- Dividend Yield
- U N/A
- JAZZ N/A
- EPS Growth
- U N/A
- JAZZ 458.10
- EPS
- U N/A
- JAZZ 7.04
- Revenue
- U $1,965,424,000.00
- JAZZ $3,992,712,000.00
- Revenue This Year
- U N/A
- JAZZ $7.43
- Revenue Next Year
- U $1.00
- JAZZ $6.39
- P/E Ratio
- U N/A
- JAZZ $17.80
- Revenue Growth
- U N/A
- JAZZ 5.23
- 52 Week Low
- U $13.90
- JAZZ $99.06
- 52 Week High
- U $43.54
- JAZZ $134.17
- Technical
- Relative Strength Index (RSI)
- U 60.20
- JAZZ 62.51
- Support Level
- U $17.29
- JAZZ $115.65
- Resistance Level
- U $23.09
- JAZZ $128.99
- Average True Range (ATR)
- U 1.32
- JAZZ 3.68
- MACD
- U 0.16
- JAZZ 0.09
- Stochastic Oscillator
- U 89.14
- JAZZ 80.79
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.